Disease Progression Is Main Barrier to Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.12.378
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2018
Authors
Publisher
Elsevier BV